Journalartikel

A regenerative strategy for heart failure in hypoplastic Left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells


AutorenlisteRupp, Stefan; Zeiher, Andreas M.; Dimmeler, Stefanie; Tonn, Torsten; Bauer, Juergen; Jux, Christian; Akintuerk, Hakan; Schranz, Dietmar

Jahr der Veröffentlichung2010

Seiten574-577

ZeitschriftThe Journal of Heart and Lung Transplantation

Bandnummer29

Heftnummer5

ISSN1053-2498

eISSN1557-3117

DOI Linkhttps://doi.org/10.1016/j.healun.2009.10.006

VerlagElsevier


Abstract
Novel surgical strategies have dramatically improved the initial outcome of newborns with hypoplastic left heart syndrome. However, the single systemic right ventricle remains a major challenge, with limited effectiveness of pharmacologic therapy. The present case documents that the intracoronary administration of autologous bone marrow-derived progenitor cells is technically feasible in a critically ill infant with hypoplastic left heart syndrome and severe heart failure after a hybrid comprehensive stage II procedure. Cell therapy might represent an option before heart transplantation in children with single ventricle physiology presenting with severe heart failure. J Heart Lung Transplant 2010;29:574-577 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.



Zitierstile

Harvard-ZitierstilRupp, S., Zeiher, A., Dimmeler, S., Tonn, T., Bauer, J., Jux, C., et al. (2010) A regenerative strategy for heart failure in hypoplastic Left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells, The Journal of Heart and Lung Transplantation, 29(5), pp. 574-577. https://doi.org/10.1016/j.healun.2009.10.006

APA-ZitierstilRupp, S., Zeiher, A., Dimmeler, S., Tonn, T., Bauer, J., Jux, C., Akintuerk, H., & Schranz, D. (2010). A regenerative strategy for heart failure in hypoplastic Left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells. The Journal of Heart and Lung Transplantation. 29(5), 574-577. https://doi.org/10.1016/j.healun.2009.10.006



Schlagwörter


ACUTE MYOCARDIAL-INFARCTIONautologous stem cell therapyCARDIAC REPAIRHLHSTRANSPLANTATION


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:42